Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
164M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
56.1M
-
Shares change
-
-8.3M
-
Total reported value, excl. options
-
$41.2M
-
Value change
-
-$6.52M
-
Put/Call ratio
-
0.54
-
Number of buys
-
51
-
Number of sells
-
-66
-
Price
-
$0.73
Significant Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q2 2025
141 filings reported holding NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q2 2025.
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.1M shares
of 164M outstanding shares and own 34.2% of the company stock.
Largest 10 shareholders include SOFTBANK GROUP CORP. (6.54M shares), VANGUARD GROUP INC (4.76M shares), MIC Capital Management UK LLP (4.46M shares), Siren, L.L.C. (4.36M shares), FMR LLC (3.5M shares), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31M shares), BlackRock, Inc. (2.88M shares), ICONIQ Capital, LLC (2.56M shares), Lunate Capital Ltd (2.12M shares), and T. Rowe Price Investment Management, Inc. (2.1M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.